CS8700282A2 - Nicorandil-containing stable pharmaceutical - Google Patents

Nicorandil-containing stable pharmaceutical

Info

Publication number
CS8700282A2
CS8700282A2 CS87282A CS28287A CS8700282A2 CS 8700282 A2 CS8700282 A2 CS 8700282A2 CS 87282 A CS87282 A CS 87282A CS 28287 A CS28287 A CS 28287A CS 8700282 A2 CS8700282 A2 CS 8700282A2
Authority
CS
Czechoslovakia
Prior art keywords
nicorandil
stable pharmaceutical
containing stable
pharmaceutical
stable
Prior art date
Application number
CS87282A
Other languages
English (en)
Other versions
CS276587B6 (en
Inventor
Yoskhimitsu Iida
Shuji Sumida
Original Assignee
Yoskhimitsu Iida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26342067&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CS8700282(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yoskhimitsu Iida filed Critical Yoskhimitsu Iida
Publication of CS8700282A2 publication Critical patent/CS8700282A2/cs
Publication of CS276587B6 publication Critical patent/CS276587B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS87282A 1986-01-17 1987-01-15 Stable nicorandil-containing pharmaceutical agent CS276587B6 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP772286 1986-01-17
JP6185686 1986-03-19

Publications (2)

Publication Number Publication Date
CS8700282A2 true CS8700282A2 (en) 1991-07-16
CS276587B6 CS276587B6 (en) 1992-07-15

Family

ID=26342067

Family Applications (1)

Application Number Title Priority Date Filing Date
CS87282A CS276587B6 (en) 1986-01-17 1987-01-15 Stable nicorandil-containing pharmaceutical agent

Country Status (21)

Country Link
US (1) US4822808A (cs)
EP (1) EP0230932B1 (cs)
KR (1) KR940000232B1 (cs)
CN (1) CN1009525B (cs)
AR (1) AR241514A1 (cs)
AU (1) AU591958B2 (cs)
CA (1) CA1285486C (cs)
CS (1) CS276587B6 (cs)
DE (1) DE3769662D1 (cs)
DK (1) DK174918B1 (cs)
EG (1) EG18088A (cs)
ES (1) ES2054623T3 (cs)
FI (1) FI87043C (cs)
GR (1) GR3002288T3 (cs)
HK (1) HK66193A (cs)
HU (1) HU196705B (cs)
MX (1) MX167912B (cs)
NO (1) NO173590C (cs)
NZ (1) NZ218917A (cs)
PT (1) PT84124B (cs)
SG (1) SG64893G (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637322A (en) * 1992-11-06 1997-06-10 Japan Tobacco Inc. Method for producing composition for solid medicine
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
ATE308342T1 (de) * 1997-08-08 2005-11-15 Chugai Pharmaceutical Co Ltd Arzneimittel gegen diabetes-komplikationen
AU748359B2 (en) * 1998-05-15 2002-06-06 Chugai Seiyaku Kabushiki Kaisha Controlled-release formulations
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
FR2872705B1 (fr) * 2004-07-08 2008-07-18 Aventis Pharma Sa Compositions contenant du nicorandil, procede de preparation et utilisation
WO2008112227A1 (en) * 2007-03-12 2008-09-18 Reliant Pharmaceuticals, Inc. Treatment with nicorandil and omega-3 fatty acids, and a combination product thereof
SI2098249T1 (sl) * 2008-03-05 2013-02-28 Rivopharm Sa Nosilci nikorandila s povečano stabilnostjo
KR20100007082A (ko) * 2008-07-11 2010-01-22 주식회사 엘지생명과학 니코란딜을 포함하는 서방성 제제
CN102186474A (zh) * 2008-08-14 2011-09-14 杏林制药株式会社 稳定的医药组合物
ES2768651T3 (es) 2013-04-25 2020-06-23 Kyorin Seiyaku Kk Composición farmacéutica sólida
CN110123749B (zh) * 2019-06-03 2022-01-25 太阳升(亳州)生物医药科技有限公司 尼可地尔脂微球制剂及其制备方法
CN111574441B (zh) * 2020-05-26 2021-12-31 中国科学院上海药物研究所 一种尼可地尔与水杨酸的共晶及其制备方法和应用
CN115429763B (zh) * 2021-06-02 2024-01-02 北京四环科宝制药股份有限公司 尼可地尔片剂及其制备方法
CN114732792A (zh) * 2022-03-25 2022-07-12 北京诺康达医药科技股份有限公司 一种尼可地尔口腔崩解片及其制备方法
CN115317456A (zh) * 2022-08-17 2022-11-11 北京科源创欣科技有限公司 一种尼可地尔片组合物及其制备方法
CN115282123B (zh) * 2022-09-13 2023-11-03 南京比逊医药科技有限公司 一种稳定的尼可地尔制剂的制备方法
CN117547534B (zh) * 2023-11-10 2024-07-12 江南大学 尼可地尔缓释制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168438A (en) * 1962-08-09 1965-02-02 Synergistics Inc Vasodilation by nitric acid ester derivatives of nicotinic acid
US3332848A (en) * 1963-07-10 1967-07-25 Hoffmann La Roche Microcrystalline cellulose with starch in niacinamide ascorbic acid tablet granulations
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
US4490377A (en) * 1980-07-29 1984-12-25 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
JPS57145659A (en) * 1981-03-06 1982-09-08 Chugai Pharmaceutical Co Ltd Production of tablet
US4382091A (en) * 1981-04-30 1983-05-03 Syntex (U.S.A.) Inc. Stabilization of 1-substituted imidazole derivatives in talc
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent

Also Published As

Publication number Publication date
HUT44435A (en) 1988-03-28
FI87043C (fi) 1992-11-25
CA1285486C (en) 1991-07-02
FI87043B (fi) 1992-08-14
CN87100285A (zh) 1987-08-19
AR241514A1 (es) 1992-08-31
NO173590C (no) 1994-01-05
AU6764887A (en) 1987-07-23
EG18088A (en) 1992-08-30
FI870131L (fi) 1987-07-18
PT84124A (en) 1987-02-01
DK19187A (da) 1987-07-18
ES2054623T3 (es) 1994-08-16
SG64893G (en) 1993-08-06
EP0230932A3 (en) 1987-12-09
PT84124B (pt) 1989-02-28
DK174918B1 (da) 2004-02-23
EP0230932A2 (en) 1987-08-05
KR940000232B1 (ko) 1994-01-12
EP0230932B1 (en) 1991-05-02
US4822808A (en) 1989-04-18
NO870212D0 (no) 1987-01-19
KR870006894A (ko) 1987-08-13
DE3769662D1 (de) 1991-06-06
HU196705B (en) 1989-01-30
DK19187D0 (da) 1987-01-15
MX167912B (es) 1993-04-22
NO870212L (no) 1987-07-20
GR3002288T3 (en) 1992-12-30
FI870131A0 (fi) 1987-01-14
CS276587B6 (en) 1992-07-15
NZ218917A (en) 1989-10-27
NO173590B (no) 1993-09-27
CN1009525B (zh) 1990-09-12
HK66193A (en) 1993-07-16
AU591958B2 (en) 1989-12-21

Similar Documents

Publication Publication Date Title
GB8716904D0 (en) Stable pharmaceutical preparation
GB8610572D0 (en) Pharmaceutical preparation
CS403391A3 (en) Pharmaceutical
GB8613688D0 (en) Pharmaceutical composition
GB8618847D0 (en) Pharmaceutical formulations
ZA875813B (en) Pharmaceutical compounds
CS8700282A2 (en) Nicorandil-containing stable pharmaceutical
GB2187953B (en) Pharmaceutical formulation
GB8628373D0 (en) Pharmaceutical composition
ZA877699B (en) Pharmaceutical combination
GB8709166D0 (en) Pharmaceutical composition
GB8721313D0 (en) Pharmaceutical preparation
GB8614189D0 (en) Pharmaceutical composition
GB8621008D0 (en) Pharmaceutical composition
ZA876048B (en) Pharmaceutical formulation
GR871915B (en) Pharmaceutical formulations
GB8701281D0 (en) Pharmaceutical solution
ZA871814B (en) Novel pharmaceutical combinations
GB8725539D0 (en) Pharmaceutical composition
GB8620463D0 (en) Pharmaceutical
BG43026A1 (en) Lyposomic pharmaceutical form
GB8605750D0 (en) Pharmaceutical agents
GB8600066D0 (en) Pharmaceutical agents
GB8603097D0 (en) Pharmaceutical formulations
ZA876959B (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20070115